GL1X · GenesisL1 explorer

MolNFT v1 · #6949 · protein

Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design

1FS4: “Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design”. X-ray diffraction, 2 ligands (CRA, PLP), 13 pockets (best druggability 0.84). MolNFT v1 #6949 on GenesisL1: 3D…

PDB
1FS4
Type
protein
Length
830 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase
EC
2.4.1.1
UniProt
P00489
Ligands
CRA, PLP
Pockets
13 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase (EC 2.4.1.1)protein83051% helix, 15% strandP00489

Ligands and binding sites

  • CRA · 1-deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide · ligand · chains A
  • PLP · Pyridoxal-5'-phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12820.840.9549CRA, PLP
21540.800.9643empty
33070.710.8435empty
41800.550.7924empty
51190.530.8218empty

Modifications

Observed in the structure: 1 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 1FS4 · Structures of glycogen phosphorylase-inhibitor complexes and the implications for… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.